OncoStem
Omics Related DiagnosisOncoStem
Keywords:
Oncostem Diagnostics, Cancer diagnostics solutions, Personalized cancer risk assessment, Prognostic tests, Cancer risk evaluation, Cancer screening, Cancer detection, Oncology diagnostics, Precision medicine in cancer, Molecular diagnostics, Cancer treatment planning, Cancer biomarkers, Breast cancer risk assessment, Cancer prevention, Cancer risk management
SUMMARY
CanAssist Breast developed by OncoStem, is a prognostic tool that helps in managing early-stage, hormone receptor-positive breast cancer. It evaluates multiple biomarkers in a tumor sample to calculate a risk score, which indicates the likelihood of cancer recurrence within five years post-surgery. This personalized approach aids oncologists in tailoring treatment plans, potentially sparing low-risk patients from unnecessary aggressive treatments and their side effects, while ensuring high-risk patients receive the care they need. CanAssist Breast represents a significant advancement in personalized breast cancer care, aiming to optimize treatment decisions and improve patient outcomes.
PRODUCTS
CanAssist Breast Test: This is their primary product, a prognostic test to assess the risk of breast cancer recurrence within five years post-surgery. It analyzes multiple biomarkers in the tumor tissue, offering a detailed risk score to guide personalized treatment plans
SERVICES
Personalized Risk Assessment, Diagnostic Laboratory Services, Consultation and Support
FOUNDER DETAILS
Manjiri Bakre
OncoStem Diagnostics Private Limited
Vikram Srinivasan
OncoStem
ABOUT
OncoStem pioneers in delivering personalized cancer treatment plans through innovative testing, improving patient's life quality.
COMPANY TYPE
SERVICE VERTICALS
TECHNOLOGY
THERAPEUTIC AREAS
VALUE OFFERING
LOCATION
#4, Raja Ram Mohan Roy Road, Aanand Tower, 2nd Floor, Bangalore - 560027
TARGET USERS
- HCP
- Corporate
- Patients
- Payers
INCORPORATION DATE
2011
STATE/CITY
Karnataka, Bengaluru
Uncover the depths of your favorite themes with our captivating blog selection!
News in the spotlight
Dedicated coverage of the news stories that dominate the media landscape.
INDEX DATA USAGE NOTICE
At Mocero Health, we are committed to maintaining the trust and confidence of our visitors and users. This Index Data Usage Notice explains how we collect, use, and share data related to the various indices and aggregated metrics presented on our site. Index data on Mocero Health is generated through a combination of proprietary algorithms, user interactions, and publicly available health data. This may include, but is not limited to, health condition prevalence rates, treatment effectiveness scores, healthcare facility ratings, and user search trends. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using Mocero Health, you acknowledge and agree to the collection, use, and sharing of index data as described in this notice.
CONTENT DISCLAIMER
The information provided on this website is intended for general and educational purposes only. We reserve the right to modify this content policy at any time. Changes will be effective immediately upon posting the revised policy. Your continued use of the platform after any changes signifies your agreement to the new terms. If you have concerns about how your data is used or wish to exercise your rights, please contact us at +91-9500115161. By using this site, you acknowledge and agree that you have read and understood this Content Disclaimer.
News
Stay up-to-date with news about health-tech startups, compiled and presented in a centralized platform.
Blog
Dive into the latest insights and trends with our blogs section. Each post is carefully curated to provide
you with the most valuable and actionable content, ensuring you stay informed.
Showing 1 blogs